Which has the lower trailing P/E, GMED or RGEN?

GMED has the lower trailing P/E: GMED trades at 19.65 and RGEN at 239.53. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, GMED or RGEN?

Over the past five years, GMED grew revenue faster — GMED at a 27.65% CAGR versus RGEN at 9.08%.

Is GMED or RGEN more profitable?

GMED runs the higher net margin — GMED at 17.03% versus RGEN at 5.29%.

How have GMED and RGEN total returns compared?

Over the past 10 years, GMED delivered 12.95% and RGEN delivered 20.13% annualized total return. Past performance doesn't predict future results.

Globus Medical, Inc. (GMED) vs Repligen Corporation (RGEN)

A side-by-side comparison of Globus Medical, Inc. and Repligen Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

GMED

Globus Medical, Inc.

$10.31B

$76.43HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

RGEN

Repligen Corporation

$9.87B

$174.86HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — GMED vs RGEN

growth of $100 · dividends reinvested · last 10y

GMED +224.3% (+12.5%/yr)RGEN +528.7% (+20.2%/yr)RGEN compounded faster over this window

GMED RGEN

GMED vs RGEN: by the numbers

•GMED is the larger company ($10.31B vs $9.87B market cap).
•GMED trades at the lower trailing earnings multiple (19.65 vs 239.53 P/E), one valuation lens rather than an overall verdict.
•GMED converts more revenue to profit (17.03% vs 5.29% net margin).
•GMED grew revenue faster over the past five years (27.65% vs 9.08% CAGR).

Metrics side by side

Valuation

Metric	GMED	RGEN
P/E ratio	19.65	239.53
Forward P/E	15.28	84.92
PEG ratio	0.63	N/A
P/S ratio	3.28	12.57
P/B ratio	2.16	4.67
EV / EBITDA	10.62	67.03
FCF yield	7.28%	1.12%

Profitability

Metric	GMED	RGEN
Gross margin	68.55%	51.05%
Operating margin	20.75%	8.32%
Net margin	17.03%	5.29%
ROE	11.23%	1.97%
ROIC	10.49%	1.85%

Growth (annualized)

Metric	GMED	RGEN
Revenue CAGR (5Y)	27.65%	9.08%
EPS CAGR (5Y)	30.79%	-5.26%
FCF CAGR (5Y)	29.93%	22.49%
Total return CAGR (5Y)	-0.33%	-6.86%

Frequently asked

Which has the lower trailing P/E, GMED or RGEN?: GMED has the lower trailing P/E: GMED trades at 19.65 and RGEN at 239.53. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, GMED or RGEN?: Over the past five years, GMED grew revenue faster — GMED at a 27.65% CAGR versus RGEN at 9.08%.
Is GMED or RGEN more profitable?: GMED runs the higher net margin — GMED at 17.03% versus RGEN at 5.29%.
How have GMED and RGEN total returns compared?: Over the past 10 years, GMED delivered 12.95% and RGEN delivered 20.13% annualized total return. Past performance doesn't predict future results.

Go deeper

Full GMED analysis Full RGEN analysis Interactive comparison tool

Dig into the metrics

Globus Medical P/E ratio Repligen P/E ratio Globus Medical ROE Repligen ROE Globus Medical operating margin Repligen operating margin Globus Medical revenue growth Repligen revenue growth Globus Medical free cash flow Repligen free cash flow

Globus Medical & Repligen appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.